Text Size Normal Text Sizing Button Medium Text Sizing Button Large Text Sizing Button Text Contrast Normal Contrast Button Reverse Contrast Button Switch to Spanish Language Contact Us Sitemap Sign In Register
Link to Homepage About AHAF
Donate Now Get Involved  
Alzheimer's Disease Research Macular Degeneration Research National Glaucoma Research


Sign up for Email Notifications
If you would like to be notified when submission deadlines are announced please click on the link below.

Sign up for new RFP announcements and submission deadline notifications.

This email list is not sold or distributed, and serves only as an annual reminder of the availability of research funding through the American Health Assistance Foundation (www.ahaf.org). Please follow instructions on the notification emails for removal requests.
 
AHAF Research Grants Funding
Grant Funding for Alzheimer's Research
Grant Funding for Macular Degeneration Research
Grant Funding for Glaucoma Research
 

  

Macular Degeneration Research - Current Award

Dr. Jimbo Liu

Jinbo Liu, M.D.

Cleveland Clinic Foundation
Cleveland, OH

Title: Identification of autoreactive T cells in AMD Patients
Non-Technical Title: Immune mechanism underlying AMD

Duration: April 1, 2008 - March 31, 2010
Award Type: Standard
Award Amount: $100,000


Summary:

The experiments in this proposal will address the mechanisms underlying immune attack in the retina. This information could lead to treatment approaches not currently available.

Details:

The back of the eye where light is detected is a site where light induced modifications of occular components can occur as individuals age, and these modifications accumulate. The immune system is designed to distinguish anything that differs from normal body components, so these modifications can cause the immune system to attack the back of the eye and compromise vision. The experiments in this proposal will address the mechanisms underlying this immune attack. This information could lead to treatment approaches not currently available.